2021 annual financial data

ADMA Biologics Inc - Common Stock 2021 Operating margin

ADMA Biologics Inc - Common Stock 2021 operating margin with verified reported…

Direct answer

Operating margin was -72.12%.

Operating income was -58,374,000 USD and net income was -71,648,000 USD.
Operating cash flow was -112,368,982 USD.

Verified data

Revenue
80,943,000 USD
Operating income
-58,374,000 USD
Net income
-71,648,000 USD
Operating cash flow
-112,368,982 USD